The study indicates that the clinical burden of genetic dilated cardiomyopathy (DCM) may be underestimated due to very low molecular genetic testing rates.
The clinical burden of genetic DCM may be underestimated due to very low rates of molecular genetic testing in clinical practice.
Absolute Event Rate: 0% vs 0%
This study establishes a conservative period prevalence for DCM and idiopathic DCM and demonstrates very low molecular genetic testing for DCM. These findings suggest that the clinical burden of genetic DCM may be underestimated.
Ababio et al. (Fri,) reported a other. The study indicates that the clinical burden of genetic dilated cardiomyopathy (DCM) may be underestimated due to very low molecular genetic testing rates.